Antares Pharma, Inc. (ATRS)

Net Receivables

$93.28M

Quarterly · Period ending: · USD

ATRS logo

ATRS Net Receivables

Latest reported$93.28M
ATRS Quarterly Net Receivables ($100.00K → $93.28M)
High-resolution chart · PNG

ATRS net receivables history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. Net Receivables — Quarterly (USD)
Period endingNet Receivables (USD)
93,279,000
83,008,000
57,413,000
59,949,000
53,900,000
50,361,000
51,291,000
41,306,000
41,341,000
43,309,000
40,130,000
30,914,000
39,217,000
29,418,000
15,483,000
14,072,000
12,494,000
11,878,000
10,146,966
9,067,689
7,884,665
9,073,173
8,561,738
10,295,347
7,976,760
7,952,478
6,558,074
6,449,885
4,208,270
3,510,051
2,272,373
3,065,166
3,648,162
1,034,492
3,405,395
4,330,136
1,729,232
2,228,650
2,051,344
2,630,275
1,409,006
2,535,230
1,986,786
1,301,296
1,606,796
1,245,560
823,543
649,268
1,719,261
1,542,272
515,260
880,265
767,021
1,334,648
1,105,328
902,266
702,468
507,068
947,507
828,615
538,058
911,660
321,157
399,092
400,751
272,129
285,092
317,326
305,463
341,965
242,647
317,820
378,322
489,833
950,242
544,942
791,655
212,855
318,247
1,040,482
929,364
867,121
503,433
1,068,199
788,391
213,801
262,672
379,681
98,359
167,301
200,000
200,000
200,000
275,694
300,000
400,000
400,000
760,948
300,000
400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.